Ify Sargeant

823 total citations
18 papers, 356 citations indexed

About

Ify Sargeant is a scholar working on General Health Professions, Rheumatology and Economics and Econometrics. According to data from OpenAlex, Ify Sargeant has authored 18 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in General Health Professions, 5 papers in Rheumatology and 5 papers in Economics and Econometrics. Recurrent topics in Ify Sargeant's work include Mental Health and Patient Involvement (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Patient-Provider Communication in Healthcare (5 papers). Ify Sargeant is often cited by papers focused on Mental Health and Patient Involvement (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Patient-Provider Communication in Healthcare (5 papers). Ify Sargeant collaborates with scholars based in United Kingdom, United States and Switzerland. Ify Sargeant's co-authors include Anton Hoos, Jan Geißler, Marc Boutin, L Dewulf, Roslyn F. Schneider, Marilyn Metcalf, Jeanne M. Regnante, Gervais Tougas, Nicholas Brooke and James W. Anderson and has published in prestigious journals such as Lara D. Veeken, BMJ Open and Value in Health.

In The Last Decade

Ify Sargeant

17 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ify Sargeant United Kingdom 10 193 117 59 57 25 18 356
Marc Boutin United States 8 166 0.9× 161 1.4× 67 1.1× 54 0.9× 15 0.6× 17 342
Chiara Whichello United States 9 141 0.7× 250 2.1× 47 0.8× 41 0.7× 13 0.5× 25 432
Elisabeth Oehrlein United States 12 200 1.0× 180 1.5× 81 1.4× 32 0.6× 10 0.4× 34 530
Anton Hoos United Kingdom 6 148 0.8× 110 0.9× 46 0.8× 55 1.0× 21 0.8× 7 259
L Dewulf Belgium 10 121 0.6× 93 0.8× 85 1.4× 53 0.9× 23 0.9× 19 472
Lívia Lovato Pires de Lemos Brazil 11 188 1.0× 62 0.5× 92 1.6× 13 0.2× 20 0.8× 23 535
Ulrik Kihlbom Sweden 14 156 0.8× 83 0.7× 151 2.6× 12 0.2× 16 0.6× 33 456
Stuart Wright United Kingdom 12 99 0.5× 167 1.4× 72 1.2× 35 0.6× 9 0.4× 41 453
Martina Garau United Kingdom 10 107 0.6× 394 3.4× 39 0.7× 32 0.6× 9 0.4× 30 516
Karen J. Maschke United States 12 137 0.7× 82 0.7× 245 4.2× 22 0.4× 14 0.6× 37 499

Countries citing papers authored by Ify Sargeant

Since Specialization
Citations

This map shows the geographic impact of Ify Sargeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ify Sargeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ify Sargeant more than expected).

Fields of papers citing papers by Ify Sargeant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ify Sargeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ify Sargeant. The network helps show where Ify Sargeant may publish in the future.

Co-authorship network of co-authors of Ify Sargeant

This figure shows the co-authorship network connecting the top 25 collaborators of Ify Sargeant. A scholar is included among the top collaborators of Ify Sargeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ify Sargeant. Ify Sargeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Oehrlein, Elisabeth, Barry Lewis, Jim Elliott, et al.. (2025). Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today?. Therapeutic Innovation & Regulatory Science. 59(4). 737–752.
2.
Hoverd, Eleanor, Ify Sargeant, Shane Ward, et al.. (2024). Understanding the inclusion and participation of adults from Black African Diaspora Communities (BAFDC) in health and care research in the UK: a realist review protocol. BMJ Open. 14(3). e082564–e082564. 1 indexed citations
3.
Dewulf, L, et al.. (2023). Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review. Therapeutic Innovation & Regulatory Science. 58(1). 63–78. 9 indexed citations
4.
Baird, Anne‐Marie, et al.. (2023). How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action. Health Science Reports. 6(6). e1349–e1349. 10 indexed citations
5.
6.
Scott, Jessica M., Katherine Deane, Laura Dormer, et al.. (2022). Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action. Therapeutic Innovation & Regulatory Science. 56(5). 848–858. 20 indexed citations
7.
Skovlund, Søren, Dawn P. Richards, Begonya Nafría, et al.. (2019). PNS249 WHAT ARE THE PRIORITY PATIENT ENGAGEMENT ACTIVITIES IN MEDICINES DEVELOPMENT? RESULTS OF A GLOBAL MULTI-STAKEHOLDER CONSULTATION. Value in Health. 22. S328–S328. 3 indexed citations
8.
Deane, Katherine, Laure Delbecque, Anton Hoos, et al.. (2019). Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative. BMJ Innovations. 5(1). 43–55. 46 indexed citations
9.
Boudes, Mathieu, Paul Robinson, Nicholas Brooke, et al.. (2018). What do stakeholders expect from patient engagement: Are these expectations being met?. Health Expectations. 21(6). 1035–1045. 22 indexed citations
10.
Boutin, Marc, L Dewulf, Anton Hoos, et al.. (2016). Culture and Process Change as a Priority for Patient Engagement in Medicines Development. Therapeutic Innovation & Regulatory Science. 51(1). 29–38. 38 indexed citations
11.
O’Brien, Anne, et al.. (2015). Development and Validation of a Patient Reported Experience Measure (PREM) for Patients with Rheumatoid Arthritis (RA) and other Rheumatic Conditions. Current Rheumatology Reviews. 11(1). 1–7. 21 indexed citations
12.
Hoos, Anton, James W. Anderson, Marc Boutin, et al.. (2015). Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action. Therapeutic Innovation & Regulatory Science. 49(6). 929–939. 132 indexed citations
13.
14.
Edwards, C J, et al.. (2012). TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE. Lara D. Veeken. 51. 129–130. 1 indexed citations
15.
Edwards, C J, et al.. (2012). REGIONAL DIFFERENCES IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM. Lara D. Veeken. 51. 129–129. 3 indexed citations
16.
Choy, Ernest, et al.. (2012). Variation in the use of biologics in the management of rheumatoid arthritis across the UK. Current Medical Research and Opinion. 28(10). 1733–1741. 9 indexed citations
17.
Penn-Barwell, Jowan G., et al.. (2009). PVL Staphylococcus Aureus Osteomyelitis Complicating Septic Arthritis in a Uk Soldier Serving in Iraq. Journal of the Royal Army Medical Corps. 155(3). 208–209. 5 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Boutin Breakdown of academic impact, for papers by Chiara Whichello Breakdown of academic impact, for papers by Elisabeth Oehrlein Breakdown of academic impact, for papers by Anton Hoos Breakdown of academic impact, for papers by L Dewulf Breakdown of academic impact, for papers by Lívia Lovato Pires de Lemos Breakdown of academic impact, for papers by Ulrik Kihlbom Breakdown of academic impact, for papers by Stuart Wright Breakdown of academic impact, for papers by Martina Garau Breakdown of academic impact, for papers by Karen J. Maschke
Rankless by CCL
2026